Active Pharmaceutical Ingredient Cannabinoids

Through our exclusive partnerships with some of the largest API cannabinoid manufacturers, we supply a wide range of synthetic or hemp-derived cannabinoids as Active Pharmaceutical Ingredient, exclusively for the pharmaceutical industry.

Active Pharmaceutical Ingredient cannabinoids are typically used in the pharmaceutical industry for the R&D of new cannabinoid-based drugs. The rising popularity of CBD in the wellbeing consumer market, as well as the interest in CBD and other cannabinoids from the scientific community has resulted in a boom of cannabinoid research in the pharmaceutical industry.

SparkCBD can supply a wide range of API cannabinoids in large quantities, including:

  • Cannabidiol (CBD)

  • Cannabidiolic acid (CBDA)

  • Δ9 THC

  • Δ9-Tetrahydrocannabinolic acid (THCA)

  • Δ8 THC

  • Tetrahydrocannabivarin (THCV)

  • Cannabigerol (CBG)

  • Cannabigerolic acid (CBGA)

  • Cannabidivarin (CBDV)

  • Cannabidivarinic acid (CBDVA)

  • Cannabichromene (CBC)

  • Cannabichromenic acid (CBCA)

  • Cannabinol (CBN)

  • Cannabinolic acid (CBNA)

  • Cannabicyclol (CBL)

  • Cannabicyclolic acid (CBLA)

Any pharmaceutical company involved in R&D and new drug formulation understands the importance of having a stable and consistent supply of API material, both during the R&D process, as well as during the drug approval process and going to market with their newly approved drug.

SparkCBD takes out the countless hours of research, looking for reliable suppliers for API cannabinoid material. With an extensive network of accredited, established and reliable manufacturers of hemp-derived and synthetic API cannabinoids both in the USA and Europe, we will connect you with the ideal suppliers for your specific requirements.

API Cannabinoids Bulk

Our Active Pharmaceutical Ingredient cannabinoids can be supplied as either GMP or non-GMP certified, hemp-derived or synthetic, according to clients’ requirements. Contact us to discuss your requirements.